Joanne brings to Jnana broad life sciences experience in chemical biology and disease biology, operations, business and partnerships. Joanne came to Jnana from F-Prime, where she was assistant director of the F-Prime Biomedical Research Initiative, an effort focused on advancing the discovery of novel therapeutic treatments neurodegenerative diseases. Prior to this, Joanne was a director at the Broad Institute, where she was involved in creating and guiding project teams and partnerships to advance chemical probe and drug discovery efforts, including serving as alliance manager for the Broad-Bayer collaborations in oncology and cardiovascular disease.Joanne received a PhD in chemistry from the University of California, Berkeley and conducted postdoctoral research at Genentech and the Necker Children’s Hospital in Paris. Before Broad, she was at Nature Publishing Group, first as a founding editor of the journal Nature Chemical Biology and later as a senior editor at the translational newsletter SciBX.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Jnana Therapeutics | Co-founder and CEO | Nov 1, 2018 | — | Detail |